56 168

Cited 28 times in

Aspirin enhances TRAIL-induced apoptosis via regulation of ERK1/2 activation in human cervical cancer cells.

Authors
Im, SR; Jang, YJ
Citation
Biochemical and biophysical research communications, 424(1):65-70, 2012
Journal Title
Biochemical and biophysical research communications
ISSN
0006-291X1090-2104
Abstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers tumor-specific apoptosis. However, some tumors and cancer cell lines are resistant to TRAIL. Here, the effect of the non-steroidal anti-inflammatory drug aspirin on sensitization of human cervical cancer cells to TRAIL and the underlying mechanism(s) of the effect were explored. Combination treatment with aspirin and TRAIL markedly enhanced apoptotic cell death, as assessed by lactate dehydrogenase (LDH) assay and analysis of cell cycle sub-G1 phase. The two agents together activated the several caspases and mitochondrial signaling pathway. Whereas Mcl-1 protein level was increased and extracellular signal-related kinase (ERK)1/2 was activated in cells treated with TRAIL alone, combination treatment dramatically inhibited ERK1/2 activation and down-regulated Mcl-1 protein level. An inhibitor of ERK1/2 activation, PD98059, also augmented TRAIL-induced apoptosis. Combination treatment with PD98059 and TRAIL showed the activation of caspases and mitochondrial pathway, and the down-regulation of Mcl-1 level. These results suggest that cancer cells can be sensitized to TRAIL-induced apoptosis by pre-treatment with aspirin via suppression of ERK1/2 activation. These findings provide a basis for further exploring the potential applications of this combination approach for the treatment of cancer, including cervical cancer.
MeSH terms
Apoptosis/*drug effectsAspirin/*pharmacology/therapeutic useCaspases/biosynthesisEnzyme ActivationFemaleHeLa CellsHumansMAP Kinase Signaling System/*drug effectsMitogen-Activated Protein Kinase 1/*antagonists & inhibitorsMitogen-Activated Protein Kinase 3/*antagonists & inhibitorsProto-Oncogene Proteins c-bcl-2/metabolismTNF-Related Apoptosis-Inducing Ligand/*pharmacology/therapeutic useUterine Cervical Neoplasms/drug therapy/*enzymology
DOI
10.1016/j.bbrc.2012.06.067
PMID
22728039
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Microbiology
AJOU Authors
장, 영주
Full Text Link
Files in This Item:
fulltext not available.txtDownload
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse